| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |